Artificial Intelligence (AI) techniques can be applied to primary care data to facilitate the early diagnosis of cancer, according to the first international review of studies on this topic.
A new study, led by researchers at the University of Cambridge, will investigate the feasibility of developing a full kidney cancer screening clinical trial.
The most ambitious international research ever conducted on the inheritance of breast cancer is published today (20 January) in the New England Journal of Medicine.